Knee Pain, Arthritis & Degeneration: How Stem Cell Therapy Regrows Cartilage in Chester County

    Dr. Darris Wine

    Knee Pain Is America's Most Common Joint Complaint

    Chronic knee pain affects roughly 25% of adults, and knee arthritis (osteoarthritis) is the most common form of arthritis worldwide. In Chester County and across the Delaware Valley, we see patients every week who have been told their only option is knee replacement surgery.

    Common causes of chronic knee pain include:

    • Knee osteoarthritis – progressive cartilage loss in the knee joint
    • Knee degeneration – age-related wear and tear
    • Meniscus damage – tears in the knee's shock-absorbing cartilage
    • Bone-on-bone contact – advanced cartilage deterioration

    How Stem Cell Therapy Regenerates the Knee

    Our stem cell treatment literally regrows cartilage in the knee joint space. Here's how:

    1. Concentrated regenerative cells are injected directly into your knee joint
    2. These cells stimulate new tissue growth — creating fresh cartilage where it was lost
    3. Inflammation decreases as the joint environment improves
    4. Over weeks and months, patients experience restored cushioning and reduced knee pain

    Our Track Record with Knee Pain

    Knee arthritis and knee degeneration are the conditions we treat most frequently at Renew Life Medical. Many patients report:

    • Significant reduction in chronic knee pain
    • Improved ability to walk, climb stairs, and exercise
    • Avoidance of knee replacement surgery
    • Results from a single treatment session

    Take the First Step

    Don't let knee pain control your life. Call (610) 429-3240 for a free consultation to find out if stem cell therapy can help your knee arthritis or degeneration.

    Important Regulatory Disclaimer

    The information in this article is for educational purposes only and does not constitute medical advice. Individual results vary. Regenerative therapies at Renew Life Medical, including Wharton's Jelly–derived products, are used strictly for homologous use in accordance with FDA regulatory requirements under Section 361 of the Public Health Service Act and 21 CFR Part 1271. We make no claims regarding the treatment, cure, or prevention of any specific disease or condition.

    Interested in Learning More?

    Schedule a consultation to discuss how regenerative medicine may benefit you.

    Book Free Consultation